See what members are saying about myasthenia gravis treatments, the side effects to expect, and the drug basics.
All treatment information is medically reviewed · October 19, 2026
Uplizna (inebilizumab-cdon) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating adults with generalized myasthenia gravis.
Bkemv (eculizumab-aeeb) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat generalized myasthenia gravis in adults.
Imaavy (nipocalimab-aahu) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating generalized myasthenia gravis in adults and children ages 12 years and older.
Zilbrysq (zilucoplan) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat generalized myasthenia gravis (gMG) in adults.
Ultomiris (ravulizumab-cwvz) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat generalized myasthenia gravis in adults.
Vyvgart (efgartigimod alfa-fcab) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating adults with generalized myasthenia gravis.
Soliris (eculizumab) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating generalized myasthenia gravis in adults and children ages 6 and older who test positive for anti-acetylcholine receptor antibodies.
In addition to generalized myasthenia gravis, Soliris is also approved for certain people with paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, and neuromyelitis optica spectrum disorder.
Rystiggo (rozanolixizumab) is a prescription medicine approved by the U.S. Food and Drug Administration (FDA) to treat adults with generalized myasthenia gravis (gMG).
Mestinon (pyridostigmine) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat myasthenia gravis in adults.
Become a member to get even more